Table III.
Covariates | uHR | Model 1 aHR | Model 2 aHR | Model 3 aHR | Model 4 aHR | Model 5 aHR | Model 6 aHR | Model 7 aHR |
---|---|---|---|---|---|---|---|---|
Race/ethnicity Black Hispanic Asian |
1.9 (1.7–2.2) 1.6 (1.3–2.0) 0.93 (0.44–2.0) |
1.7 (1.5–2.0) 1.5 (1.2–1.9) 0.96 (0.5–2.0) |
1.5 (1.3–1.7) 1.2 (1.0–1.5) 0.70 (0.33–1.5) |
1.9 (1.7–2.2) 1.6 (1.3–2.0) 0.93 (0.45–2.0) |
1.9 (1.7–2.2) 1.6 (1.3–1.9) 0.96 (0.46–2.0) |
1.9 (1.7–2.2) 1.5 (1.2–1.9) 0.83 (0.40–1.8) |
1.8 (1.6–2.1) 1.6 (1.3–2.0) 0.91 (0.41–2.0) |
1.4 (1.2–1.6) 1.2 (0.96–1.5) 0.69 (0.33–1.5) |
Demographic factors Female sex Age (years) |
0.91 (0.81–1.0) 0.98 (0.97–0.98) |
0.91 (0.8–1.0) 0.98 (0.98–0.99) |
– |
– |
– |
– |
– |
0.95 (0.83–1.1) 0.98 (0.98–0.99) |
Comorbidities Current smoker Diabetes Diabetes, insulin dependent CKD Preoperative dialysis |
0.96 (0.86–1.1) 1.7 (1.5–1.9) 1.8 (1.6–2.0) 2.3 (2.1–2.6) 2.7 (2.4–3.1) |
– |
1.1 (0.97–1.2) 1.3 (1.1–1.5) 1.4 (1.2–1.6) 1.3 (1.04–1.6) 1.7 (1.3–2.2) |
– | – | – | – |
1.0 (0.87–1.2) 1.2 (1.04–1.5) 1.2 (1.02–1.4) 1.3 (0.95–1.8) 1.4 (1.0–2.1) |
Optimal medical therapy Aspirin and statin |
0.92 (0.83–1.0) |
– |
– |
0.90 (0.81–1.01) |
– |
– |
– |
0.87 (0.78–0.98) |
Environmental factorsa Center volume Low center volume Medium center volume High center volume Surgeon volume Low surgeon volume Medium surgeon volume High surgeon volume |
Ref 1.1 (0.90–1.3) 1.1 (0.86–1.4) Ref 0.98 (0.86–1.1) 0.99 (0.86–1.1) |
– | – | – |
Ref 1.1 (0.92–1.3) 1.2 (0.97–1.4) Ref 0.95 (0.83–1.1) 0.97 (0.81–1.2) |
– | – |
Ref 1.0 (0.85–1.2) 1.0 (0.82–1.3) Ref 0.98 (0.85–1.2) 0.99 (0.82–1.3) |
Disease severity Rest pain Tissue loss Urgency status Elective Urgent Emergent |
Ref 1.7 (1.5–2.0) Ref 1.4 (1.3–1.6) 2.1 (1.4–3.1) |
– | – | – | – |
Ref 1.7 (1.5–1.9) Ref 1.4 (1.2–1.5) 2.0 (1.4–3.0) |
– |
Ref 1.4 (1.2–1.6) Ref 1.3 (1.1–1.5) 2.2 (1.6–3.2) |
Operative factors Infrapopliteal bypass Prosthetic conduit |
1.6 (1.4–1.7) 1.0 (0.92–1.2) |
– | – | – | – | – |
1.6 (1.4–1.8) 1.2 (1.04–1.4) |
1.4 (1.3–1.6) 1.3 (1.1–1.5) |